Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythropoietin Monotherapy for Brain Regeneration in Neonatal Encephalopathy in Low and Middle-Income Countries

NCT05395195 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT05395195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05395195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythropoietin Monotherapy for Brain Regeneration in Neonatal Encephalopathy in Low and Middle-Income Countries
Lead sponsor
Imperial College London
Phase
Phase 3
Overall status
Recruiting
Start date
December 31, 2022
Completion date
December 1, 2026
Enrollment
504 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

encephalopathy, erythropoietin, newborn asphyxia